These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8016174)

  • 1. Serum growth hormone-binding protein (GHBP) activity is decreased by administration of insulin-like growth factor I in three Laron syndrome siblings with normal GHBP.
    Silbergeld A; Klinger B; Keret R; Eshet R; Almonté AS; Laron Z
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):324-7. PubMed ID: 8016174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
    Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
    J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laron syndrome due to a post-receptor defect: response to IGF-I treatment.
    Laron Z; Klinger B; Eshet R; Kaneti H; Karasik A; Silbergeld A
    Isr J Med Sci; 1993 Dec; 29(12):757-63. PubMed ID: 8300382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM; Julius JR; Stoppani C; Rundle AC
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J; Keliner K; Zilkens T; Schmidt-Gayk H; Selisko T; Scholz GH
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) status regulates GH receptor and GH binding protein mRNA in a tissue- and transcript-specific manner but has no effect on insulin-like growth factor-I receptor mRNA in the rat.
    Butler AA; Funk B; Breier BH; LeRoith D; Roberts CT; Gluckman PD
    Mol Cell Endocrinol; 1996 Feb; 116(2):181-9. PubMed ID: 8647318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin in obese patients with Laron syndrome before and during IGF-I treatment.
    Laron Z; Silbergeld A; Lilos P; Blum FW
    J Pediatr Endocrinol Metab; 1998; 11(5):653-6. PubMed ID: 9829217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-binding protein in the goat: characterization, evolution under exogenous growth hormone treatment, and correlation with liver growth hormone receptor levels.
    Jammes H; Disenhaus C; Ouriet V; Kayser C; Postel-Vinay MC; Djiane J
    Domest Anim Endocrinol; 1996 Nov; 13(6):477-89. PubMed ID: 8960404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of GH, IGF-I and insulin on serum sex hormone binding globulin.
    Gafny M; Silbergeld A; Klinger B; Wasserman M; Laron Z
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):169-75. PubMed ID: 7923821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity growth hormone binding protein, insulin-like growth factor I and insulin-like growth factor binding protein 3 in adults with growth hormone deficiency.
    Roelen CA; Koppeschaar HP; de Vries WR; Zelissen PM; Snel YE; Doerga ME; Thijssen JH; Blankenstein RA
    Eur J Endocrinol; 1996 Jul; 135(1):82-6. PubMed ID: 8765978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3.
    Pirazzoli P; Cacciari E; De Iasio R; Pittalis MC; Dallacasa P; Zucchini S; Gualandi S; Salardi S; David C; Boschi S
    Arch Dis Child Fetal Neonatal Ed; 1997 Sep; 77(2):F100-4. PubMed ID: 9377129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) receptors, binding proteins and IGF-I concentrations in the serum of transgenic mice expressing bovine GH agonist or antagonist.
    Sotelo AI; Bartke A; Kopchick JJ; Knapp JR; Turyn D
    J Endocrinol; 1998 Jul; 158(1):53-9. PubMed ID: 9713326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
    Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
    Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment.
    Low LC; Postel-Vinay MC; Kwan EY; Cheung PT
    Clin Endocrinol (Oxf); 1998 May; 48(5):641-6. PubMed ID: 9666877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein.
    Kanety H; Silbergeld A; Klinger B; Karasik A; Baxter RC; Laron Z
    Eur J Endocrinol; 1997 Dec; 137(6):626-30. PubMed ID: 9437227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.
    Carlsson LM; Attie KM; Compton PG; Vitangcol RV; Merimee TJ
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1325-30. PubMed ID: 8200933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.